XJZY(SZ:002332) Ge Long Hui A P P·2025-10-29 04:17Group 1 - Xianju Pharmaceutical's product, injection vecuronium bromide, is expected to be selected for the 11th batch of national centralized drug procurement, with sales revenue of 14.184 million yuan from January to September 2025, accounting for 0.5% of the company's total revenue during the same period. The selected price shows a certain degree of decline compared to the original sales price, which may enhance the accessibility of the product if the procurement contract is signed and implemented [1][1][1] Group 2 - Montai High-tech's "Montai Convertible Bonds" have their last conversion day on October 29. Investors holding these bonds can convert them before market close on that day. After market close, unconverted bonds will be forcibly redeemed at a price of 101.19 yuan per bond (including tax), which may lead to potential losses for investors [1][1][1] Group 3 - Tianhe Defense has submitted an application for a specific stock issuance to the Shenzhen Stock Exchange, which has been accepted [1][1][1]